TY  -  
T1  - Diclofenac Does Not Reduce the Risk of Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis in Low-Risk Units 
SN  -  /  
UR  - http://hdl.handle.net/10138/238725 
T3  -  
A1  - Rainio, Mia; Lindström, Outi; Udd, Marianne; Louhimo, Johanna; Kylänpää, Leena 
A2  -  
PB  -  
Y1  - 2017 
LA  - eng 
AB  - Background Nonsteroidal anti-inflammatory drugs have an inhibitory role in pathogenesis of pancreatitis. Guidelines from the European Society of Gastrointestinal Endoscopy recommend routine rectal administration of 100 mg of diclofenac or indomethacin immediately before or after ERCP for all patients without contraindications. Aims Our aim was to evaluate the effect of diclofenac in preventing post-ERCP pancreatitis (PEP) in a high-volume, low-PEP-risk ERCP unit. Methods The rate and severity of... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - Acute pancreatitis; Diclofenac; ERCP; ESGE recommendation; Post-ERCP pancreatitis; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ERCP PANCREATITIS; RECTAL INDOMETHACIN; RANDOMIZED-TRIAL; METAANALYSIS; PREVENTION; COMPLICATIONS; NSAIDS; SPHINCTEROTOMY; MULTICENTER; 3126 Surgery, anesthesiology, intensive care, radiology 
N1  -   
PP  -  
ER  -